SGMT – sagimet biosciences inc. (US:NASDAQ)
Stock Stats
News
Sagimet Biosciences Inc. (NASDAQ: SGMT) had its "neutral" rating re-affirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $6.00 price target on the stock, down previously from $23.00.
COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors [Yahoo! Finance]
Sagimet Biosciences (NASDAQ:SGMT) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Sagimet Biosciences Inc. (NASDAQ: SGMT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Sagimet Biosciences to Host Conference Call and Webcast to Discuss Recently Presented Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat [Yahoo! Finance]
Form 8-K/A Sagimet Biosciences Inc. For: Jun 05
Form 4 Sagimet Biosciences Inc. For: Jun 05 Filed by: Walbert Timothy P
Form 4 Sagimet Biosciences Inc. For: Jun 05 Filed by: Parsey Merdad
Form 4 Sagimet Biosciences Inc. For: Jun 05 Filed by: SEIDENBERG BETH C
Form 4 Sagimet Biosciences Inc. For: Jun 05 Filed by: Hoelscher Paul W.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.